Send me a link:

*Text messaging rates may apply.

 Dow Up 0.13% Nasdaq Down 0.10%

OncoMed Pharmaceuticals, Inc. (OMED)

-NasdaqGS
22.00 Down 0.84(3.68%) 4:00PM EDT
Prev Close:22.84
Open:23.00
Bid:21.00 x 300
Ask:26.00 x 500
1y Target Est:43.20
Beta:1.637
Next Earnings Date:N/A
Day's Range:21.56 - 23.00
52wk Range:12.07 - 42.34
Volume:188,117
Avg Vol (3m):154,659
Market Cap:650.21M
P/E (ttm):N/A
EPS (ttm):-1.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OMED

Comparison

Symbol% ChgMkt Cap
OMEDDown 3.68%650.21M
STMLDown 3.51%148.84M
VSTMDown 4.10%205.64M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.52
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.76
Quarterly EPS Est (Jun-14) :-0.03
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoMed Pharmaceuticals, Inc., a clinical development-stage biotechnology company, focuses on discovering and developing monoclonal antibody therapeutics targeting cancer stem Cells (CSCs). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback